Role of serum and salivary microRNAs as diagnostic biomarkers in gastric cancer

Introduction: Incidence of Gastric cancer (GC) is increasing alarmingly in the recent past due to changing lifestyle and diet pattern. GC usually has poor prognosis due to delayed diagnosis. Salivary and serum biomarkers are a potential early diagnostic tool for GC. MicroRNAs are promising biomarker...

Full description

Bibliographic Details
Main Authors: Thangavelu Radhika, Sundaram Gopalakrishnan, Ramalingam Sathish Muthukumar, Mahalingam Arulpari, Bondili Suresh Kumar, Rajeswary Hari, Madhan Jeyaraman, Nadeem Jeddy
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Journal of Orofacial Sciences
Subjects:
Online Access:http://www.jofs.in/article.asp?issn=0975-8844;year=2023;volume=15;issue=2;spage=182;epage=188;aulast=Radhika
_version_ 1797300032358055936
author Thangavelu Radhika
Sundaram Gopalakrishnan
Ramalingam Sathish Muthukumar
Mahalingam Arulpari
Bondili Suresh Kumar
Rajeswary Hari
Madhan Jeyaraman
Nadeem Jeddy
author_facet Thangavelu Radhika
Sundaram Gopalakrishnan
Ramalingam Sathish Muthukumar
Mahalingam Arulpari
Bondili Suresh Kumar
Rajeswary Hari
Madhan Jeyaraman
Nadeem Jeddy
author_sort Thangavelu Radhika
collection DOAJ
description Introduction: Incidence of Gastric cancer (GC) is increasing alarmingly in the recent past due to changing lifestyle and diet pattern. GC usually has poor prognosis due to delayed diagnosis. Salivary and serum biomarkers are a potential early diagnostic tool for GC. MicroRNAs are promising biomarkers due to their stability in these body fluids and their pivotal role in carcinogenesis. This study helps to determine the role of serum and salivary microRNAs as diagnostic biomarkers in gastric cancer. Materials and Methods: The systematic review was performed as per the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. The population, intervention, comparison, outcomes, and study (PICOS) framework was used as a strategy for this review. The data were retrieved from online databases such as Medline (PubMed), Web of Science, Scopus, and SpringerLink. Risk of bias and applicability concerns were evaluated using the four domains of QUADAS-2: patient selection, index test, reference standard, procedure and timing. Results: Quality evaluation based on diagnostic accuracy revealed that five studies conducted by Hou et al., Jianhong et al., Kaczor-Urbanowicz et al., Saliminejad et al., and So JBY et al. had the lowest risk of bias, according to a risk of bias chart created using Revman 5.4.1 software. A serum 12-miRNA biomarker assay was validated by the low risk of bias research. Conclusion: This systematic review provides an insight into the possible role and application of an array of miRNAs from various body fluids as a biomarker for the early detection of gastric cancer. The serum 12-miRNA biomarker assay, validated by a low risk of bias research can serve as a potential diagnostic tool to detect gastric cancer. However, the validation of other salivary, serum, and plasma miRNAs as a diagnostic biomarker for gastric cancer mandates further long-term follow-up studies in diverse ethnicity of populations.
first_indexed 2024-03-07T23:00:20Z
format Article
id doaj.art-a3096dbec13b407bbae274d953626543
institution Directory Open Access Journal
issn 0975-8844
language English
last_indexed 2024-03-07T23:00:20Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Orofacial Sciences
spelling doaj.art-a3096dbec13b407bbae274d9536265432024-02-22T15:03:50ZengWolters Kluwer Medknow PublicationsJournal of Orofacial Sciences0975-88442023-01-0115218218810.4103/jofs.jofs_228_23Role of serum and salivary microRNAs as diagnostic biomarkers in gastric cancerThangavelu RadhikaSundaram GopalakrishnanRamalingam Sathish MuthukumarMahalingam ArulpariBondili Suresh KumarRajeswary HariMadhan JeyaramanNadeem JeddyIntroduction: Incidence of Gastric cancer (GC) is increasing alarmingly in the recent past due to changing lifestyle and diet pattern. GC usually has poor prognosis due to delayed diagnosis. Salivary and serum biomarkers are a potential early diagnostic tool for GC. MicroRNAs are promising biomarkers due to their stability in these body fluids and their pivotal role in carcinogenesis. This study helps to determine the role of serum and salivary microRNAs as diagnostic biomarkers in gastric cancer. Materials and Methods: The systematic review was performed as per the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. The population, intervention, comparison, outcomes, and study (PICOS) framework was used as a strategy for this review. The data were retrieved from online databases such as Medline (PubMed), Web of Science, Scopus, and SpringerLink. Risk of bias and applicability concerns were evaluated using the four domains of QUADAS-2: patient selection, index test, reference standard, procedure and timing. Results: Quality evaluation based on diagnostic accuracy revealed that five studies conducted by Hou et al., Jianhong et al., Kaczor-Urbanowicz et al., Saliminejad et al., and So JBY et al. had the lowest risk of bias, according to a risk of bias chart created using Revman 5.4.1 software. A serum 12-miRNA biomarker assay was validated by the low risk of bias research. Conclusion: This systematic review provides an insight into the possible role and application of an array of miRNAs from various body fluids as a biomarker for the early detection of gastric cancer. The serum 12-miRNA biomarker assay, validated by a low risk of bias research can serve as a potential diagnostic tool to detect gastric cancer. However, the validation of other salivary, serum, and plasma miRNAs as a diagnostic biomarker for gastric cancer mandates further long-term follow-up studies in diverse ethnicity of populations.http://www.jofs.in/article.asp?issn=0975-8844;year=2023;volume=15;issue=2;spage=182;epage=188;aulast=Radhikasalivabiomarkersserummicrornagastric cancer
spellingShingle Thangavelu Radhika
Sundaram Gopalakrishnan
Ramalingam Sathish Muthukumar
Mahalingam Arulpari
Bondili Suresh Kumar
Rajeswary Hari
Madhan Jeyaraman
Nadeem Jeddy
Role of serum and salivary microRNAs as diagnostic biomarkers in gastric cancer
Journal of Orofacial Sciences
saliva
biomarkers
serum
microrna
gastric cancer
title Role of serum and salivary microRNAs as diagnostic biomarkers in gastric cancer
title_full Role of serum and salivary microRNAs as diagnostic biomarkers in gastric cancer
title_fullStr Role of serum and salivary microRNAs as diagnostic biomarkers in gastric cancer
title_full_unstemmed Role of serum and salivary microRNAs as diagnostic biomarkers in gastric cancer
title_short Role of serum and salivary microRNAs as diagnostic biomarkers in gastric cancer
title_sort role of serum and salivary micrornas as diagnostic biomarkers in gastric cancer
topic saliva
biomarkers
serum
microrna
gastric cancer
url http://www.jofs.in/article.asp?issn=0975-8844;year=2023;volume=15;issue=2;spage=182;epage=188;aulast=Radhika
work_keys_str_mv AT thangaveluradhika roleofserumandsalivarymicrornasasdiagnosticbiomarkersingastriccancer
AT sundaramgopalakrishnan roleofserumandsalivarymicrornasasdiagnosticbiomarkersingastriccancer
AT ramalingamsathishmuthukumar roleofserumandsalivarymicrornasasdiagnosticbiomarkersingastriccancer
AT mahalingamarulpari roleofserumandsalivarymicrornasasdiagnosticbiomarkersingastriccancer
AT bondilisureshkumar roleofserumandsalivarymicrornasasdiagnosticbiomarkersingastriccancer
AT rajeswaryhari roleofserumandsalivarymicrornasasdiagnosticbiomarkersingastriccancer
AT madhanjeyaraman roleofserumandsalivarymicrornasasdiagnosticbiomarkersingastriccancer
AT nadeemjeddy roleofserumandsalivarymicrornasasdiagnosticbiomarkersingastriccancer